Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996 Sep; 153(9):1147-53.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.